NEW YORK --(BUSINESS WIRE)--Sep. 30, 2019-- In the first sentence of the release, the date and time should read: Monday, October 7, 2019 at 8:00 a.m. Eastern Time (instead of: Monday, October 7, 2019 at 8:30 a.m. Eastern Time ). The corrected release reads:   IVERIC BIO TO PRESENT…

  NEW YORK --(BUSINESS WIRE)--Sep. 30, 2019-- IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Glenn P. Sblendorio , Chief Executive Officer and President of IVERIC bio, will present an overview of the Company at the Chardan Capital Markets 3 rd Annual Genetic Medicines Conference in New York

NEW YORK --(BUSINESS WIRE)--Sep. 17, 2019-- IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Kourous A. Rezaei , MD, Chief Medical Officer of IVERIC bio, will present an overview of the Company at the Ladenburg Thalmann 2019 Healthcare Conference in New York on Tuesday, September 24, 2019 at